07/2022 ACTIGRAFT Presentation in the government Oncologic hospital in Tashkent, full conference room with around 50 doctors and surgeons under the hospitality of the hospital’s general manager. Presentation and discussion…
ACTIGRAFTPRP (Platelet-rich plasma)PRF, Growth factors & other blood productsA three-dimensional matrix containing a fibrin net, which forms a stable basis for growth factors and blood vessels, migration of cells, capturing…
06/2022 – Actigraft has received the approval of the Ministry of Health in Uzbekistan. We will start our activities soon, aiming to improving life quality for those suffering from diabetic…
Recreating the Natural Wound Healing Environment Meet ActiGraft®: ActiGraft® is a Biological Wound Care Device/ Treatment for chronic wounds management. Actigraft is the first wound care product that enables health…
04/2022 An innovative wound care system to help the wounded, has arrived in Ukraine – Thanks to the collaboration between RedDress, a Florida-based Medical Company, Graft-In, a Cypriot medical marketing…
03/2022 – Actigraft has received the approval of the Ministry of Health in Azerbaijan. We are launching the activity in hospitals and clinics countrywide.
03/2022: Graft-In took part in the WUW conference for wound in the UAE exhibition. together with the manufacturer Redders and our local distributor Imperial Middle East, the Actigraft treatment was…
02/2022 – Actigraft has received the approval of the Ministry of Health in Ukraine. SALAVAMED, our official partner there, is launching the activity in hospitals and clinics in order to…
11.2021 - Graft-in started cooperation on the Ministry of Health in Azerbaijan. The activity began in a conference at the University Hospital in Baku with the introduction of ACTIGRAFT to…
On 15.12.2021, Graft-in and Imperial Middle East with the assistance of consider consultancy, launched the joint activity in the UAE for ACTIGRAFT® treatments in hospitals in Abu Dhabi and Dubai.